Study of Oral Atogepant Tablets to Assess Safety and Efficacy in Adult Participants With Migraine
Clinical trial NCT06241313 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06241313
- Sponsor
- AbbVie
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-25
- Primary completion
- 2025-07-07
- Enrollment
- 1300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.